SartreJP. L'existentialism est un humanisme. Lecture delivered in 1945 at the Club Maintenant. In: MairetP, Transl. Existentialism & Humanism. London: Methuen & Co. Ltd, 1989.
4.
WarnockM. Existentialism. Oxford: Oxford University Press, 1970:125.
5.
SartreJP. L'Etre et le Néant. 1943. In: BarnesHE, Transl. Being and Nothingness. London: Methuen & Co. Ltd, 1958.
6.
QuinnNHallettM. Dose standardisation of botulinum toxin. Lancet1989;i:964.
7.
HambletonPCapelBBaileyNHeronNCrooksAMellingJProduction, purification and toxoiding of Clostridium botulinum type A toxin. In: LewisGE, ed. Biomedical Aspects of Botulism. New York: Academic Press, 1981:247–60.
8.
CriselyFD. Demonstration of botulinum toxins and clostridium botulism in food. In: LewisKHAngelottiR, eds. Examination of Foods for Enteropathogenic and Indicator Bacteria. Washington DC: US Department of Health, Education and Welfare, 1964:55–79.
9.
BuchananNSmitLCaneRDDe-AndradeM. Sympathetic overactivity in tetanus: fatality associated with propranolol.
10.
SouthornPABlaiseGA. Treatment of tetanus-induced autonomic nervous system dysfunction with continuous epidural blockade. Crit Care Med1986;14:251–2.
11.
RieMWilsonRS. Morphine therapy controls autonomic hyperactivity in tetanus. Ann Intern Med1978;88:653–4.
12.
SuttonDNTremlettMRWoodcockTENielsenMS. Management of autonomic dysfunction in severe tetanus; the use of magnesium sulphate and clonidine. Intensive Care Med1990;16:75–80.
13.
AhmadsyahISalimA. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. BMJ1985;291:648–50.
14.
BleckTP. Tetanus. In: ScheldWMWhitleyRJDurackDT, eds. Infections Of the Central Nervous System. New York: Raven Press, 1991:603–24.
15.
BuchananNSmitLCaneRDDe AndradeM. Sympathetic overactivity in tetanus: Fatality associated with propranolol. BMJ1978;2:254–5.
16.
WesleyAGHariparsadDPatherMRockeDA. Labetolol in tetanus. The treatment of sympathetic nervous system overactivity. Anaesthesia1983;38:243–9.
17.
EdmondsonRSFlowersMW. Intensive care in tetanus; management, complications and mortality in 100 cases. BMJ1979;1:1401–4.
18.
TseudaKOliverPBRichterRW. Cardiovascular manifestations of tetanus. Anesthesiology1974;40:588–92.
19.
AbrutynE. Tetanus. In: WilsonJDBraunwaldEIsselbacherKJPetersdorfRGMartinJBFauciAS eds. Harrison's Principles of Internal Medicine, 12th edn.New York: McGraw-Hill International Book Co., 1991:577–9.
20.
AhmadsyahISalimA. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. BMJ1985;291:648–50.
21.
Medical letter. The choice of anti-microbial drugs. Med Lett Drugs Ther1990;32:41.
22.
WaltonJ. Tetanus. In: Brain's Diseases of the Nervous System, 10th edn.New York: Oxford University Press, 1993:303–5.
23.
GreenMSetchellJHamesPStiffGTouquetRPriestR. Management of alcohol abusing patients in accident and emergency departments. J R Soc Med1993;86:393–5.
24.
BarrettTVaughan WilliamsC. Use of a questionnaire to obtain an alcohol history from those attending an inner city accident and emergency department. Arch Emerg Med1989;6:34–40.
25.
RowlandNMaynardA. Doctors have no time for alcohol screening. BMJ1987;295:95–6.
26.
ThéodoridèsJ. Le personnage du médecin dans l'oeuvre romanesque de Stendhal. Gesnerus1985;42:465–78.
27.
HserYIAnglinTMPowersK. A 24 year follow-up of Californian narcotic addicts. Arch Gen Psychiatry1993;50:577–84.
28.
SellsSBSimpsonDD. The case for drug abuse treatment effectiveness, based on the DARP research programme. Br J Addict1980;75:117–31.
29.
WatersonTDaviesJ. Could hospitals do more to encourage breast feeding?BMJ1993;307:1437–8.